Kahveci, Ali Murat, and Veysel Tahan. “Daclatasvir Plus Sofosbuvir Regimen Sheds Promising Light on Future Hepatitis C Virus Genotype 3 Therapies”. Turkish Journal of Gastroenterology, vol. 27, no. 1, Jan. 2016, pp. 89-90, doi:10.5152/tjg.2015.150012.